One recent study implicated miR-1908 as a cancer biomarker.65 A further study found that miR-1908 belonged to a miRNA cluster that downregulates the MARK1 signaling pathway, thus altering cell proliferation and differentiation.66 The gene discussed is MARK1; the disease is cancer.